Current Gastroenterology Reports

, Volume 11, Issue 5, pp 420–427

Serrated adenomas

  • Wilfredo E. De Jesus-Monge
  • Carmen Gonzalez-Keelan
  • Marcia Cruz-Correa
Article

Abstract

Serrated adenomas are categorized as sessile serrated adenomas (SSAs) and traditional serrated adenomas (TSAs). SSAs are more prevalent in the proximal colon and lack classic dysplasia, whereas TSAs are more prevalent in the rectosigmoid and have cytologic dysplasia. Serrated adenomas may progress to colorectal adenocarcinoma through diverse molecular alterations. Colonoscopy is the only test for the early detection of serrated adenomas that allows inspection of the entire colon and same-session biopsy sampling or polypectomy, if necessary. If an endoscopic biopsy at the right colon reveals SSA without cytologic dysplasia or biopsy at the rectosigmoid reveals SSA or TSA, those polyps should be excised or surgically resected as necessary. Postpolypectomy surveillance for removed SSAs without dysplasia and TSAs must be performed at 5- and 3-year intervals, respectively, with colonoscopy to prevent recurrence and progression to colorectal adenocarcinoma.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    O’Brien MJ: Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 2007, 36:947–968.PubMedCrossRefGoogle Scholar
  2. 2.
    Longacre TA, Fenoglio-Preiser CM: Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 1990, 14:524–537.PubMedGoogle Scholar
  3. 3.
    Aaltonen LA, Hamilton SR: World Health Organization, International Agency for Research on Cancer. Pathology and Genetics of Tumours of the Digestive System. Lyon, Oxford: IARC Press; 2000.Google Scholar
  4. 4.
    Torlakovic E, Skovlund E, Snover DC, et al.: Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003, 27:65–81.PubMedCrossRefGoogle Scholar
  5. 5.
    Groff RJ, Nash R, Ahnen DJ: Significance of serrated polyps of the colon. Curr Gastroenterol Rep 2008, 10:490–498.PubMedCrossRefGoogle Scholar
  6. 6.
    Carr NJ, Mahajan H, Tan KL, et al.: Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 2009, 62:516–518.PubMedCrossRefGoogle Scholar
  7. 7.
    Spring KJ, Zhao ZZ, Karamatic R, et al.: High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006, 131:1400–1407.PubMedCrossRefGoogle Scholar
  8. 8.
    Mansoor I: Clinicopathological analysis of serrated adenomas of the colorectum. Internet Journal of Pathology 2003, 2. Available at http://www.ispub.com/journal/the_internet_journal_of_pathology/volume_2_number_2_44/article/clinicopathological_analysis_of_serrated_adenomas_of_the_colorectum.html. Accessed July 2009.
  9. 9.
    Li SC, Burgart L: Histopathology of serrated adenoma, its variants, and differentiation from conventional adenomatous and hyperplastic polyps. Arch Pathol Lab Med 2007, 131:440–445.PubMedGoogle Scholar
  10. 10.
    Torlakovic EE, Gomez JD, Driman DK, et al.: Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 2008, 32:21–29.PubMedCrossRefGoogle Scholar
  11. 11.
    Jass JR: Gastrointestinal polyposes: clinical, pathological and molecular features. Gastroenterol Clin North Am 2007, 36:927–946.PubMedCrossRefGoogle Scholar
  12. 12.
    Torlakovic E, Snover DC: Serrated adenomatous polyposis in humans. Gastroenterology 1996, 110:748–755.PubMedCrossRefGoogle Scholar
  13. 13.
    Sieber OM, Segditsas S, Knudsen AL, et al.: Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly but depend on the site of the germline mutation. Gut 2006, 55:1440–1448.PubMedCrossRefGoogle Scholar
  14. 14.
    Cruz-Correa M, Giardiello FM: Familial adenomatous polyposis. Gastrointest Endosc 2003, 58:885–894.PubMedCrossRefGoogle Scholar
  15. 15.
    Matsumoto T, Iida M, Kobori Y, et al.: Serrated adenoma in familial adenomatous polyposis: relation to germline APC gene mutation. Gut 2002, 50:402–404.PubMedCrossRefGoogle Scholar
  16. 16.
    Jass JR, Smith M: Sialic acid and epithelial differentiation in colorectal polyps and cancer—a morphological, mucin and lectin histochemical study. Pathology 1992, 24:233–242.PubMedCrossRefGoogle Scholar
  17. 17.
    Jass JR, Whitehall VL, Young J, Leggett BA: Emerging concepts in colorectal neoplasia. Gastroenterology 2002, 123:862–876.PubMedCrossRefGoogle Scholar
  18. 18.
    Vogelstein, B, Fearon ER, Hamilton SR, et al.: Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319:525–532.PubMedGoogle Scholar
  19. 19.
    Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP: Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 2005, 124:380–391.PubMedCrossRefGoogle Scholar
  20. 20.
    Goldstein NS: Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am J Clin Pathol 2006, 125:132–145.PubMedGoogle Scholar
  21. 21.
    O’Brien MJ, Yang S, Mack C, et al.: Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 2006, 30:1491–1501.PubMedCrossRefGoogle Scholar
  22. 22.
    Umar A, Boland CR, Terdiman JP, et al.: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004, 96:261–268.PubMedCrossRefGoogle Scholar
  23. 23.
    Kambara T, Simms LA, Whitehall VL, et al.: BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004, 53:1137–1144.PubMedCrossRefGoogle Scholar
  24. 24.
    Minoo P, Baker K, Goswami R, et al.: Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 2006, 55:1467–1474.PubMedCrossRefGoogle Scholar
  25. 25.
    Arber N, Levin B: Chemoprevention of colorectal neoplasia: the potential for personalized medicine. Gastroenterology 2008, 134:1224–1237.PubMedCrossRefGoogle Scholar
  26. 26.
    Steinbach G, Lynch PM, Phillips RK, et al.: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000, 342:1946–1952.PubMedCrossRefGoogle Scholar
  27. 27.
    Cruz-Correa M, Hylind LM, Romans KE, et al.: Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 2002, 122:641–645.PubMedCrossRefGoogle Scholar
  28. 28.
    Bertagnolli MM, Eagle CJ, Zauber AG, et al.: Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006, 355:873–884.PubMedCrossRefGoogle Scholar
  29. 29.
    Baron JA, Sandler RS, Bresalier RS, et al.: A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 2006, 131:1674–1682.PubMedCrossRefGoogle Scholar
  30. 30.
    Cruz-Correa M, Shoskes DA, Sanchez P, et al.: Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2006, 4:1035–1038.PubMedCrossRefGoogle Scholar
  31. 31.
    Raju R, Cruz-Correa M: Chemoprevention of colorectal cancer. Dis Colon Rectum 2006, 49:113–124.PubMedCrossRefGoogle Scholar
  32. 32.
    Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2009. CA Cancer J Clin, 2009, 59:225–249.PubMedCrossRefGoogle Scholar
  33. 33.
    Levin B, Lieberman DA, McFarland B, et al.: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008, 134:1570–1595.PubMedCrossRefGoogle Scholar
  34. 34.
    Pabby A, Schoen RE, Weissfeld JL, et al.: Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc 2005, 61:385–391.PubMedCrossRefGoogle Scholar
  35. 35.
    Farrar WD, Sawhney MS, Nelson DB, et al.: Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol 2006, 4:1259–1264.PubMedCrossRefGoogle Scholar
  36. 36.
    Winawer S, Fletcher R, Rex D, et al.: Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003, 124:544–560.PubMedCrossRefGoogle Scholar
  37. 37.
    Matsumoto T, Mizuno M, Shimizu M, et al.: Serrated adenoma of the colorectum: colonoscopic and histologic features. Gastrointest Endosc 1999, 49:736–742.PubMedCrossRefGoogle Scholar
  38. 38.
    Rex DK, Bond JH, Winawer S, et al.: Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2002, 97:1296–1308.PubMedCrossRefGoogle Scholar
  39. 39.
    Winawer SJ, Zauber AG, Fletcher RH, et al.: Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006, 130:1872–1885.PubMedCrossRefGoogle Scholar
  40. 40.
    Chandra A, Sheikh AA, Cerar A, Talbot IC: Clinico-pathological aspects of colorectal serrated adenomas. World J Gastroenterol 2006, 12:2770–2772.PubMedGoogle Scholar
  41. 41.
    Farris AB, Misdraji J, Srivastava A, et al.: Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol 2008, 32:30–35.PubMedCrossRefGoogle Scholar
  42. 42.
    Kawasaki T, Nosho K, Ohnishi M, et al.: Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma. BMC Cancer 2008, 8:33.PubMedCrossRefGoogle Scholar
  43. 43.
    Kim K, Park U, Wang J, et al.: Gene profiling of colonic serrated adenomas by using oligonucleotide microarray. Int J Colorectal Dis 2008, 23:569–580.PubMedCrossRefGoogle Scholar
  44. 44.
    Owens SR, Chiosea SI, Kuan, SF: Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps. Mod Pathol 2008, 21:660–669.PubMedCrossRefGoogle Scholar
  45. 45.
    Li D, Jin C, McCulloch C, et al.: Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am J Gastroenterol 2009, 104:695–702.PubMedCrossRefGoogle Scholar
  46. 46.
    Oono Y, Fu K, Nakamura H, et al.: Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci 2009, 54:906–909.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  • Wilfredo E. De Jesus-Monge
  • Carmen Gonzalez-Keelan
  • Marcia Cruz-Correa
    • 1
  1. 1.Clinical Research CenterUniversity of Puerto Rico Medical Sciences CampusSan JuanPuerto Rico

Personalised recommendations